BioHealth News Archive
Germantown’s Intrexon Corp. opens up public offering worth up to $150 million – Washington Business Journal
Germantown-based Intrexon Corp. a synthetic biology company, plans to raise up to $150 million though a secondary offering of common stock, the company said…
Read MoreWith 30 Million REGENXBIO to Finance a Round of New Hires
Washington, D.C.-based REGENXBIO Inc., announced today that it had completed a $30 million Series C financing. The round was led by Enrick and Brookside…
Read MoreAstraZeneca, Qiagen Continue to Advance Personalized Rx, CDx Partnership around Iressa – GenomeWeb
Following AstraZeneca's December announcement that it is taking steps to reintroduce the EGFR-targeted non-small cell lung cancer drug Iressa (gefitinib) in the US, Qiagen…
Read MoreInteractive Map: Where Venture Capital Was Invested in 2014 – Venture Capital Dispatch – WSJ
Venture capital investment soared in 2014, hitting a high that hasn’t been seen since 2000. As reported in The Wall Street Journal, $52.12 billion was…
Read MoreFebruary Funding Deadlines in Cystic Fibrosis, Microfluidic Platforms, and Stem Cell-Derived Blood Product Technologies
The National Heart, Lung, and Blood Institute (NHLBI) has 3 targeted funding opportunities with deadlines in February. It’s also not too early to start…
Read MoreStartup Maryland Announces Shahab Kaviani as Entrepreneur-in-Residence
Startup Maryland (www.startupmd.org) today announced appointment of serial entrepreneur Shahab Kaviani as Entrepreneur-in-Residence (EiR). A recognized leader of startup communities globally, Kaviani brings over…
Read MorePharmAthene awarded $195M judgment in Siga case – Washington Business Journal
PharmAthene Inc. now knows how much money it stands to get in its long-running lawsuit with Siga Technologies Inc.: A judge Thursday said Siga…
Read MoreDreamIt Health alum Protenus ramps up after starting ‘from scratch’ – Technical.ly Baltimore
Nick Culbertson was a Green Beret. Robert Lord worked at a hedge fund in Connecticut. Then after a career change, both found themselves in…
Read MoreHow Technology Will Eat Medicine – Vivek Wadhwa
The most significant announcement that Apple made in 2014 wasn’t a larger-sized iPhone. It was that Apple is entering the health-care industry. With HealthKit,…
Read MoreReal Estate Developer to Raise $20M to Build Digital Health Startups
Alexandria Real Estate Equities, the largest owner and developer of real estate for the life-sciences industry in the nation wants to raise up to…
Read MoreNews Highlights:Roche to Buy Trophos for Up-to-$543M – GEN
Roche said today it will acquire Trophos for up to €470 million (about $543 million), in a deal that will expand the pharma giant’s…
Read MoreHow did Steve Case’s ‘east of the Mississippi’ venture capital prediction pan out? The results are in. – Washington Business Journal
AOL founder Steve Case predicted last January that the region east of the Mississippi River would raise more venture capital than Silicon Valley in…
Read MoreJudy Britz is wrapping up five years of public service at the helm of the BioMaryland Center
Please join us in wishing her well as she embarks on retirement and new adventures. When: January 20, 2015 4:30 p.m. - 6:00 p.m.…
Read MoreVenture Capital – Year in Review 2014 – CB Insights
Venture capital funding hit its highest annual mark since 2001 as venture investors participated in $47.3 billion across 3,617 deals. Even versus 2013, the…
Read MoreVenture capital marks ‘exciting year’ in 2014, with $341M in local deals in 4Q – Baltimore Business Journal
All that venture capital money so famously "sitting on the sideline" finally made it into company coffers in 2014. Mark McCaffrey, a partner at…
Read More